EU drug regulator to issue view on J&J vaccine side effects on April 20


FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

FRANKFURT (Reuters) - Europe's drug regulator on Friday said it would hold a press briefing on its review of very rare blood clotting disorders associated with the use of Johnson & Johnson's COVID-19 vaccine on Tuesday, April 20, at 1500 GMT.

The European Medicines Agency (EMA) had previously announced it would provide an update on its review of the cases, which have occurred in the United States, next week. It has so far maintained that the benefits of the shot outweighed the risk of any side effects.

(Reporting by Ludwig Burger; Editing by Tom Sims)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

French envoy warns Lebanese leaders against 'collective suicide'
Palestinian gunmen killed after firing on Israeli base in West Bank
Iran's Khamenei says fight against Israel is a public duty
Man draws penises over potholes in New Zealand to force authorities to fix roads faster
Poland, Hungary push against "gender equality" at EU social summit
Firefighters tackle blaze at 19-storey London tower block
Pakistan PM Khan in Saudi Arabia to discuss relations
Lost in the Mediterranean, a starving grey whale must find his way home soon
Myanmar junta says seeks stability before allowing ASEAN envoy visit
Germany says production capacity, not patents, key to upping vaccine output

Stories You'll Enjoy


Vouchers